Pathstone Holdings, LLC Portage Biotech Inc. Call Options Transaction History
Pathstone Holdings, LLC
- $21.2 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding PRTG
# of Institutions
27Shares Held
2.16MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.67MShares$249,8820.01% of portfolio
-
Bison Wealth, LLC213KShares$32,0090.02% of portfolio
-
Peak6 Investments LLC Chicago, IL55.3KShares$8,2890.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny32.8KShares$4,9240.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny31.7KShares$4,7490.0% of portfolio
About PORTAGE BIOTECH INC.
- Ticker PRTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,943,700
- Market Cap $2.54M
- Description
- Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...